Skip to main content
SpringerLink
Log in

Synthesis and biological evaluation of 125I-nebivolol as a potential cardioselective agent for imaging β1-adrenoceptors

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

The aim of this study was to develop a potential selective radiopharmaceutical for the non-invasive assessment of cardiac β1-adrenoceptors in vivo. Nebivolol is a cardioselective β1-adrenergic receptor antagonist that was successfully labeled with NCA 125I via direct electrophilic substitution at ambient temperature. The reaction parameters studied were nebivolol concentration, pH of the reaction mixture and kinds of oxidizing agents. The radiolabeled compound maintained its stability throughout working period of 24 h. In vivo uptake of 125I-nebivolol in the heart was 8.51 ± 0.01% ID/organ at 0.5 h post-injection, whereas the clearance pathways from the rats appear to proceed via the hepatobiliary and renal clearance. Administration of cold nebivolol reduced the heart uptake to 2.1 ± 0.13% and further confirms the high specificity and selectivity of this radiotracer for the myocardial β1-adrenoceptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Scheme 1
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. The British Pharmacopeia (1993) vol I. The Stationery Office Books, London

  2. Pawels PJ, Gommery W, Van Lommen G, Janssen PAJ, Leysen JE (1989) Mol Pharmacol 34:843

    Google Scholar 

  3. Pawels PJ, Gommery W, Van Gompel P, Leysen JE (1991) Biochem Pharmacol 42:1683

    Article  Google Scholar 

  4. Daily Med browser, National Library of Medicine, National Institutes of Health, USA [updated 10/2004], available from: http://dailymed.nlm.nih.gov/dailymed/

  5. Münzel T, Gori T (2009) J Am Coll Card 54:16

    Article  Google Scholar 

  6. Bundkirchena A, Nguyena Q, Brixiusa K, Bölck B, Mehlhorn U, Schwingera RHG (2003) Eur J Pharmacol 476:97

    Article  Google Scholar 

  7. Brixiusa K, Bundkirchena A, Bölck B, Mehlhorn U, Schwinger RHG (2001) Br J Pharmacol 133:1330

    Article  Google Scholar 

  8. Maack C, Tyroller S, Schnabel P, Cremers B, Dabew E, SuÈdkamp M, BoÈhm M (2001) Br J Pharmacol 132:1817

    Article  CAS  Google Scholar 

  9. Mangrella M, Rossi F, Fici F (1998) Pharmacol Res 38:419

    Article  CAS  Google Scholar 

  10. Schnabel P, Maack C, Mies F, Tyroller S, Scheer A, Böhm M (2000) J Cardiovasc Pharmacol 36:466

    Article  CAS  Google Scholar 

  11. Smith C, Teitler M (1999) Cardiovasc Drugs Ther 13:123

    Article  CAS  Google Scholar 

  12. Cheng YC, Prussoff WH (1973) Biochem Pharmacol 22:3099

    Article  CAS  Google Scholar 

  13. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Nature 214:597

    Article  CAS  Google Scholar 

  14. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wislon C, Wilson S (1984) Nature 309:163

    Article  CAS  Google Scholar 

  15. Bond RA, Clarke DE (1988) Br J Pharmacol 95:723

    CAS  Google Scholar 

  16. Sarsero D, Molenaar P, Kaumann AJ, Freestone NS (1999) Br J Pharmacol 128:1445

    Article  CAS  Google Scholar 

  17. Summers RJ (2008) Br J Pharmacol 155:285

    Article  CAS  Google Scholar 

  18. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF (2008) Nature 454:486

    Article  CAS  Google Scholar 

  19. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) Science 318:1258

    Article  CAS  Google Scholar 

  20. Brodde OE, Michel MC (1999) Pharmacol Rev 51:651

    CAS  Google Scholar 

  21. Kaumann AJ (1997) Trends Pharmacol Sci 18:70

    Article  CAS  Google Scholar 

  22. Strosberg AD, Gerhardt C, Gros J, Jockers R, Piétri-Rouxel F (1998) Trends Pharmacol Sci 19:165

    Article  CAS  Google Scholar 

  23. Kompa AR, Summers RJ (1999) Br J Pharmacol 128:1399

    Article  CAS  Google Scholar 

  24. Brodde OE, Bruck H, Leineweber K, Seyfarth T (2001) Basic Res Cardiol 96:528

    Article  CAS  Google Scholar 

  25. Molenaar P, Parsonage WA (2005) Trends Pharmacol Sci 26:368

    Article  CAS  Google Scholar 

  26. Brodde OE, Bruck H, Leineweber K (2006) J Pharmacol Sci 100:323

    Article  CAS  Google Scholar 

  27. Anthonio RL, Brodde OE, van Veldhuisen DJ, Scholtens E, Crijns HJ, van Gilst WH (2000) Int J Cardiol 72:137

    Article  CAS  Google Scholar 

  28. Schäfers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG (1998) Circ Res 82:57

    Google Scholar 

  29. Castellano M, Böhm M (1997) Hypertension 29:715

    CAS  Google Scholar 

  30. Yamada S, Ohkura T, Uchida S, Inabe K, Iwatani Y, Kimura R, Hoshino T, Kaburagi T (1996) Life Sci 58:1737

    Article  CAS  Google Scholar 

  31. Khamssi M, Brodde OEJ (1996) Cardiovasc Pharmacol 16(Suppl 5):S133

    Google Scholar 

  32. Brodde OE, Zerkowski HR, Doetsch N, Motomura S, Khamssi M, Michel MCJ (1989) Am Coll Cardiol 14:323

    Article  CAS  Google Scholar 

  33. Schäfers M, Riemann B, Levkau B, Wichter T, Schäfers K, Kopka K, Breithardt G, Schober O (2002) Nucl Med Commun 23:113

    Article  Google Scholar 

  34. Kopka K, Wagner S, Riemann B, Law MP, Puke C, Luthra S, Pike V, Wichter T, Schmitz W, Schobera O, Schäfers M (2003) Bioorg Med Chem 11:3513

    Article  CAS  Google Scholar 

  35. Kopka K, Law MP, Breyholz HJ, Faust A, Höltke C, Riemann B, Schober O (2005) Curr Med Chem 12:2057

    Article  CAS  Google Scholar 

  36. Law MP, Wagner S, Kopka K, Rennera C, Pike VW, Schober O, Schäfers M (2010) Nucl Med Biol 37:517

    Article  CAS  Google Scholar 

  37. Dubois EA, van den Bos JC, Doornbos T, van Doremalen PA, Somsen GA, Vekemans JA, Janssen AG, Batink HD, Boer GJ, Pfaffendorf M, van Royen EA, van Zwieten PA (1996) J Med Chem 39:3256

    Article  CAS  Google Scholar 

  38. Van den Bos C, van Doremalen PA, Dubois E, Somsen GA, Vekemans JA, Janssen AG, Boer GJ, Pfaffendorf M, van Royen EA, van Zwieten PA (1997) Nucl Med Biol 24:1

    Article  Google Scholar 

  39. Dubois EA, Somsen GA, van den Bos JC, Janssen AG, Batink HD, Boer GJ, van Royen EA, van Zwieten PA (1997) Nucl Med Biol 24:9

    Article  CAS  Google Scholar 

  40. Delforge J, Syrota A, Lancon JP, Nakajima K, Loch C, Janier M, Vallois JM, Cayla J, Crouzel C (1991) J Nucl Med 32:739

    CAS  Google Scholar 

  41. Elsigna PH, van Waarde A, Jaeggi KA, Schreiber G, Heldoorn M, Vaalburg W (1997) J Med Chem 40:3829

    Article  Google Scholar 

  42. de Jong RM, Willemsen ATM, Slart RHJA, Blanksma PK, van Waarde A (2005) Eur J Nucl Med Mol Imaging 32:443

    Article  Google Scholar 

  43. Valette H, Dolle F, Guenther I, Demphel S, Rasetti C, Hinnen F, Fuseau C, Crouzel C (1999) Nucl Med Biol 26:105

    Article  CAS  Google Scholar 

  44. Soloviev DV, Matarrese M, Moresco RM, Todde S, Buonasera TA, Sudati F, Simonelli P, Magni F, Colombo D, Carpinelli A, Kienle MG, Fazio F (2001) Neurochem Int 38:169

    Article  CAS  Google Scholar 

  45. Elsigna PH, van Waarde A, Visser GM, Vaalburg W (1994) Nucl Med Biol 21:207

    Google Scholar 

  46. van Waarde A, Meeder JG, Blanksma PK, Brodde OE, Visser GM, Elsinga PH, Paans AMJ, Vaalburg W, Lie KI (1992) Eur J Pharmacol 1:107

    Article  Google Scholar 

  47. Pike VW, Law MP, Osman S, Davenport RJ, Rimordi O, Giardina D, Camici PG (2000) Pharm Acta Helv 74:191

    CAS  Google Scholar 

  48. Prisant LM (2008) J Clin Pharmacol 48(2):225

    Article  CAS  Google Scholar 

  49. Greenwood N, Earnshaw A (1997) Chemistry of the elements, 2nd edn. Butterworth Heinemann, Oxford

    Google Scholar 

  50. Gupta Y, Shrivastava A, Duggal D, Patel A, Agrawal S (2009) J Young Pharm 1:264

    Article  CAS  Google Scholar 

  51. Adam MJ, Wilbur DS (2005) Chem Soc Rev 34:153

    Article  CAS  Google Scholar 

  52. El-Azony KM (2010) J Radioanal Nucl Chem 285:320

    Article  Google Scholar 

  53. Tolmachev V, Bruskin A, Sivaev I, Lundqvist H, Sjöberg S (2002) Radiochem Acta 90:229

    Article  CAS  Google Scholar 

  54. Puttaswamy M, Sukhdev A, Shubha JP (2009) J Mol Catal A Chem 310:24

    Article  CAS  Google Scholar 

  55. Puttaswamy M, Vaz N (2003) Trans Met Chem 28(4):409–417

    Article  Google Scholar 

  56. Ramalingaiah H, Jagadeesh RV, Puttaswamy M (2007) J Mol Catal A Chem 265:70

    Article  CAS  Google Scholar 

  57. Cotton FA, Wilkinson G (1998) Advanced inorganic chemistry, 5th edn. Wiley, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Labeled Compound Department, Hot Lab. Centre, Atomic Energy Authority, P.O. Box 13759, Cairo, Egypt

    M. A. Motaleb & I. T. Ibrahim

  2. Chemistry Department, Faculty of Science, Benha University, Benha, Egypt

    M. E. Moustapha

Authors
  1. M. A. Motaleb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. E. Moustapha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. T. Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. E. Moustapha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motaleb, M.A., Moustapha, M.E. & Ibrahim, I.T. Synthesis and biological evaluation of 125I-nebivolol as a potential cardioselective agent for imaging β1-adrenoceptors. J Radioanal Nucl Chem 289, 239–245 (2011). https://doi.org/10.1007/s10967-011-1069-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-011-1069-z

Keywords

Search

Navigation